| Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome p450 3a and p-glycoprotein | |
| Zhao, Shan; Wu, Jingjing; Zhang, Ying; Sun, Dongsheng; Liao, Han; Liu, Yang; Sun, Guangwei | |
| 刊名 | Cancer science
 |
| 2018-12-01 | |
| 卷号 | 109页码:224-224 |
| ISSN号 | 1349-7006 |
| WOS研究方向 | Oncology |
| WOS类目 | Oncology |
| 语种 | 英语 |
| 出版者 | WILEY |
| WOS记录号 | WOS:000453773601043 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2372925 |
| 专题 | 大连化学物理研究所 |
| 作者单位 | Chinese Acad Sci, Dalian Inst Chem Phys, Beijing, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhao, Shan,Wu, Jingjing,Zhang, Ying,et al. Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome p450 3a and p-glycoprotein[J]. Cancer science,2018,109:224-224. |
| APA | Zhao, Shan.,Wu, Jingjing.,Zhang, Ying.,Sun, Dongsheng.,Liao, Han.,...&Sun, Guangwei.(2018).Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome p450 3a and p-glycoprotein.Cancer science,109,224-224. |
| MLA | Zhao, Shan,et al."Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome p450 3a and p-glycoprotein".Cancer science 109(2018):224-224. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论